Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction.
Schirinzi T, Lattanzi R, Maftei D, Grillo P, Zenuni H, Boffa L, Albanese M, Simonetta C, Bovenzi R, Maurizi R, Loccisano L, Vincenzi M, Greco A, Di Girolamo S, Mercuri NB, Passali FM, Severini C. Schirinzi T, et al. Among authors: passali fm. Brain Behav Immun. 2023 Feb;108:302-308. doi: 10.1016/j.bbi.2022.12.017. Epub 2022 Dec 19. Brain Behav Immun. 2023. PMID: 36549578 Free PMC article.
Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499.
Guerrieri M, Francavilla B, Fiorelli D, Nuccetelli M, Passali FM, Coppeta L, Somma G, Bernardini S, Magrini A, Di Girolamo S. Guerrieri M, et al. Among authors: passali fm. Vaccines (Basel). 2023 Jan 13;11(1):172. doi: 10.3390/vaccines11010172. Vaccines (Basel). 2023. PMID: 36680041 Free PMC article.
Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction.
Schirinzi T, Maftei D, Grillo P, Bovenzi R, Bissacco J, Simonetta C, Mascioli D, Zenuni H, Cerroni R, Vincenzi M, Maurizi R, Passali FM, Di Girolamo S, Ralli M, Magliulo G, Tirassa P, Stefani A, Mercuri NB, Lattanzi R, Severini C. Schirinzi T, et al. Among authors: passali fm. Mov Disord. 2023 Jul;38(7):1364-1366. doi: 10.1002/mds.29433. Epub 2023 May 8. Mov Disord. 2023. PMID: 37157902 No abstract available.
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway.
Schirinzi T, Maftei D, Maurizi R, Albanese M, Simonetta C, Bovenzi R, Bissacco J, Mascioli D, Boffa L, Di Certo MG, Gabanella F, Francavilla B, Di Girolamo S, Mercuri NB, Passali FM, Lattanzi R, Severini C. Schirinzi T, et al. Among authors: passali fm. Mol Neurobiol. 2024 Apr 4. doi: 10.1007/s12035-024-04157-w. Online ahead of print. Mol Neurobiol. 2024. PMID: 38570429
Multidisciplinary Decision-Making-ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study).
De Corso E, Pipolo C, Caminati M, Cantone E, Seccia V, Cecchi L, Nettis E, Garzaro M, Ottaviano G, Gelardi M, Cavaliere C, Heffler E, Pagella F, Pasquini E, Trimarchi M, Gallo S, La Mantia I, Torretta S, Mattavelli D, Caruso C, Matucci A, Vultaggio A, Bellocchi G, Alicandri Ciufelli M, Fm P, Senna G. De Corso E, et al. Among authors: fm p. Curr Allergy Asthma Rep. 2024 Mar;24(3):143-154. doi: 10.1007/s11882-024-01135-z. Epub 2024 Mar 12. Curr Allergy Asthma Rep. 2024. PMID: 38472601 Review.
Local allergic rhinitis: considerations.
Bellussi LM, Passali FM, Passali D. Bellussi LM, et al. Among authors: passali fm. Multidiscip Respir Med. 2023 Dec 19;18(1):939. doi: 10.4081/mrm.2023.939. eCollection 2023 Jan 17. Multidiscip Respir Med. 2023. PMID: 38322132 Free PMC article.
Rhinosinusitis: clinical-based phenotyping.
Ciprandi G, Passali D, Bellussi LM, Passali FM. Ciprandi G, et al. Among authors: passali fm. Acta Biomed. 2022 Oct 26;93(5):e2022211. doi: 10.23750/abm.v93i5.12633. Acta Biomed. 2022. PMID: 36300245 Free PMC article.
116 results